Westerkirk Capital »

ResMed shares owned by Westerkirk Capital

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Westerkirk Capital from 13F filings

Historical chart of Westerkirk Capital investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Westerkirk Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Westerkirk Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $411k 1.5k 273.73
2025-06-30 $439k 1.7k 258.00

More positions owned by Westerkirk Capital

Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Mastercard Incorporated Cl A (MA)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
TJX Companies (TJX)
Canadian Pacific Kansas City (CP)

View all positions for Westerkirk Capital

Top funds holding ResMed

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
Invesco
Northern Trust
Charles Schwab Investment Management
Legal & General Group
Ubs Global Asset Management Americas
UBS Group
FMR
Goldman Sachs Group
Dimensional Fund Advisors

View all funds holding ResMed